Evaluation of Ischemia-Modified Albumin in Patients with Inflammatory Bowel Disease        
Yazarlar (8)
Gülcan Güntaş
Kırklareli Üniversitesi, Türkiye
Prof. Dr. Abdurahman ŞAHİN Fırat Üniversitesi, Türkiye
Şermin Duran
Training And Research Hospital, Türkiye
Resul Kahraman
Umranive Training Ami Research Hospital, Türkiye
İlyas Duran
Medeniyet University Coztepe Education And Research Hospital, Türkiye
Çiğdem Sönmez
Dr. Abdurahmanyurtarslan Oncology Education And Research Hospital, Türkiye
Turan Çalhan
Umranive Training Ami Research Hospital, Türkiye
Hacı Mehmet Sökmen
Umranive Training Ami Research Hospital, Türkiye
Makale Türü Açık Erişim Özgün Makale
Makale Alt Türü SSCI, AHCI, SCI, SCI-Exp dergilerinde yayınlanan tam makale
Dergi Adı Clinical Laboratory
Dergi ISSN 1433-6510 Wos Dergi Scopus Dergi
Dergi Tarandığı Indeksler SCI-Expanded
Dergi Grubu Q4
Makale Dili İngilizce
Basım Tarihi 01-2017
Cilt No 63
Sayı 2
Sayfalar 341 / 347
DOI Numarası 10.7754/Clin.Lab.2016.160623
Özet
Background: Inflammatory bowel disease (IBD) is considered a chronic gastrointestinal inflammatory disease with unknown etiology. Oxidative stress has been demonstrated to play a critical role in the pathophysiology of IBD. We aimed to investigate the effect of the ischemia-modified albumin (IMA) and CRF levels on the pathophysiology and activities of IBD and its subgroups. Methods: The study included 39 patients with Crohn's disease (CD) and 41 patients with ulcerative colitis (UC). Thirty-three healthy volunteers participated in the study as the control group. The IMA concentrations were determined by colorimetric method. Results: IMA levels were significantly higher in IBD than in the controls (p = 0.02). In the subgroups of IBD, IMA levels were significantly lower in the control group and CD group than in UC (p < 0.001 and p < 0.001, respectively) while IMA levels were significant higher in the UC when compared with the CD group (p < 0.001). C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR) levels were significantly higher in the CD group compared to the control group (p < 0.01 and p < 0.02, respectively). Conclusions: Higher IMA level, which is a marker of oxidative stress in diseases with inflammation, indicates that inflammation and oxidative stress are related in the pathogenesis of IBD.
Anahtar Kelimeler
Crohn's disease | CRP | Ischemia-modified albumin | Oxidative stress | Ulcerative colitis